[Federal Register Volume 60, Number 122 (Monday, June 26, 1995)] [Notices] [Page 32986] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 95-15561] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of a Closed Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following Heart, Lung, and Blood Special Emphasis Panel (SEP) meeting: Name of SEP: Lung Specific Drug Delivery Systems for Tuberculosis Treatment. Date: July 18, 1995. Time: 8:00 a.m. Place: Hyatt Regency, Bethesda, Maryland. Contact Person: Carl A. Ohata, Ph.D., 6701 Rockledge Drive, Room 7198, Bethesda, Maryland 20892-7924, (301) 435-0297. Purpose/Agenda: To review and evaluate grant applications. The meeting will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications and/or proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications and/or proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. (Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; and 93.839, Blood Diseases and Resources Research, National Institutes of Health.) Dated: June 19, 1995. Susan K. Feldman, Committee Management Officer, NIH. [FR Doc. 95-15561 Filed 6-23-95; 8:45 am] BILLING CODE 4140-01-M